Blog

Treatment for NSCLC After Progression on Immunotherapy – OncLive

Treatment for NSCLC After Progression on Immunotherapy
OncLive
Five years ago, to think that we had immunotherapy? And now we're using it in pretty much all patients, and they're all benefitting (to some extent). But what we have to remember is that it's really only about 10% of the patients who have those amazing …

2017-10-05 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.